Maria De Santis is a medical oncologist and has been Associate Professor of Medicine at Paracelsus Medizinische Privatuniversität in Salzburg, Austria, since 2008. She has been working as a senior consultant at the 3rd Medical Department --- Center of Oncology and Hematology at Kaiser Franz Josef-Spital in Vienna for 18 years, where she also has been chair of the Genito-Urinary Oncology Service since 2004.
In May 2015 she was appointed Associate Clinical Professor for Oncology at the University of Warwick, Coventry, and working clinically in genitourinary oncology at the Queen Elizabeth Hospital, Cancer Center, in Birmingham, UK.
Dr De Santis is a member of several international scientific committees, including the European Society of Medical Oncology, the European Association of Urology, the European Cancer Organization, and the German Society for Hematology and Oncology. She also served as a scientific committee member of the American Society of Clinical Oncology for a 3 year term. She has authored multiple peer-reviewed articles in genito-urinary cancer medicine. In addition, Dr De Santis is a panel member of the European Association of Urology Scientific Office and Guidelines Board and the International Consultation on Urologic Diseases guideline groups on bladder, testicular and prostate cancer. Her research interests include prostate, bladder, renal and testicular cancer.
- van der Poel, Henk G., van den Bergh, Roderick C.N., Briers, Erik, Cornford, Philip, Govorov, Alex, Henry, Ann M., Lam, Thomas B., Mason, Malcolm D., Rouvière, Olivier, De Santis, Maria, Wiegel, Thomas, Willemse, Peter-Paul M., van Poppel, Hendrik, Mottet, Nicolas, 2019. Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84?91. European Urology, 75 (2), pp. e23-e24
- Gallacher, Daniel C., Armoiry, Xavier, Auguste, Peter, Court, Rachel A., Mantopoulos, Theodoros, Patterson, Jacoby, De Santis, Maria, Cresswell, Joanne, Mistry, Hema, 2019. Pembrolizumab for previously treated advanced or metastatic urothelial cancer : an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics, 37, pp. 19-27
- Fackrell, D., Marshall, A. (Andrea)?, Mistry, Pankaj, Dunn, Janet A., De Santis, Maria, Ford, D., Zarkar, A., 2018. Radical treatment of muscle-invasive bladder cancer-are options equal?. Journal of Radiation Oncology, 7 (2), pp. 181-186
- MacLennan, Sara J., MacLennan, Steven, Bex, Axel, Catto, James W.F., De Santis, Maria, Glaser, Adam W., Ljungberg, Borje, N'Dow, James, Plass, Karin, Trapero-Bertran, Marta, Van Poppel, Hendrik, Wright, Penny, Giles, Rachel H., 2017. Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder Engagement. European Urology, 72 (2), pp. 161-163
- Fossati, Nicola, Willemse, Peter-Paul M., van den Bergh, Roderick C. N., Van den Broeck, Thomas, Yuan, Cathy Yuhong, Briers, Erik, Bellmunt, Joaquim, Bolla, Michel, Cornford, Philip, De Santis, Maria, MacPepple, Ekelechi, Henry, Ann M., Mason, Malcolm D., Matveev, Vsevolod B., van der Poel, Henk G., van der Kwast, Theo H., Rouvière, Olivier, Schoots, Ivo G., Wiegel, Thomas, Lam, Thomas B. et al (Select to open full list), 2017. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer : a systematic review. European Urology, 72 (1), pp. 84-109
- Cornford, Philip, Bellmunt, Joaquim, Bolla, Michel, Briers, Erik, De Santis, Maria, Gross, Tobias, Henry, Ann M., Joniau, Steven, Lam, Thomas B., Mason, Malcolm D., van der Poel, Henk G., van der Kwast, Theo H., Rouvière, Olivier, Wiegel, Thomas, Mottet, Nicolas, 2017. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II : treatment of relapsing, metastatic, and castration-resistant prostate cancer. European Urology, 71 (4), pp. 630-642
- Pham, M. N., Apolo, A. B., De Santis, Maria, Galsky, M. D., Leibovich, B. C., Pisters, L. L., Siefker-Radtke, A. O., Sonpavde, G., Steinberg, G. D., Sternberg, C. N., Tagawa, S. T., Weizer, A. Z., Woods, M. E., Milowsky, M. I., 2017. Upper tract urothelial carcinoma topical issue 2016 : treatment of metastatic cancer. World Journal of Urology, 35 (3), pp. 367-378
- Alfred Witjes, J., Lebret, Thierry, Compérat, Eva M., Cowan, Nigel C., De Santis, Maria, Bruins, Harman Maxim, Hernández, Virginia, Espinós, Estefania Linares, Dunn, James, Rouanne, Mathieu, Neuzillet, Yann, Veskimäe, Erik, van der Heijden, Antoine G., Gakis, Georgios, Ribal, Maria J., 2017. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. European Urology, 71 (3)
- Mottet, Nicolas, Bellmunt, Joaquim, Bolla, Michel, Briers, Erik, Cumberbatch, Marcus G., De Santis, Maria, Fossati, Nicola, Gross, Tobias, Henry, Ann M., Joniau, Steven, Lam, Thomas B., Mason, Malcolm D., Matveev, Vsevolod B., Moldovan, Paul C., van den Bergh, Roderick C.N., Van den Broeck, Thomas, van der Poel, Henk G., van der Kwast, Theo H., Rouvière, Olivier, Schoots, Ivo G. et al (Select to open full list), 2017. EAU?ESTRO?SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local Treatment with curative intent. European Urology, 71 (4), pp. 618-629
- Bellmunt, Joaquim, Mottet, Nicolas, De Santis, Maria, 2016. Urothelial carcinoma management in elderly or unfit patients. European Journal of Cancer Supplements, 14 (1), pp. 1-20
- De Santis, Maria, Saad, Fred, 2016. Practical guidance on the role of corticosteroids in the treatment of metastatic castration-resistant prostate cancer. Urology, 96, pp. 156-164
- Caffo, Orazio, Thompson, Catherine, De Santis, Maria, Kragelj, Borut, Hamstra, Daniel A., Azria, David, Fellin, Gianni, Pappagallo, Giovanni L., Galligioni, Enzo, Choudhury, Ananya, 2016. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer : a pooled individual data analysis of eight phase I?II trials. Radiotherapy and Oncology, 121 (2), pp. 193-198
- Gillessen, S., De Santis, Maria, Rothermundt, C., 2016. On nonharming : the debate continues in Stage I testicular cancer. Journal of Clinical Oncology
- Dittrich, Christian, Kosty, Michael, Jezdic, Svetlana, Pyle, Doug, Berardi, Rossana, Bergh, Jonas, El-Saghir, Nagi, Lotz, Jean-Pierre, Österlund, Pia, Pavlidis, Nicholas, Purkalne, Gunta, Awada, Ahmad, Banerjee, Susana, Bhatia, Smita, Bogaerts, Jan, Buckner, Jan, Cardoso, Fatima, Casali, Paolo, Chu, Edward, Close, Julia Lee et al (Select to open full list), 2016. ESMO / ASCO recommendations for a global curriculum in medical oncology Edition 2016. ESMO Open, 1 (5)
- Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., Soule, H. R., Akaza, H., Beer, T. M., Beltran, H., Chinnaiyan, A. M., Daugaard, G., Davis, I. D., De Santis, Maria, Drake, C. G., Eeles, R. A. et al (Select to open full list), 2015. Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Annals of Oncology, 26 (8), pp. 1589-1604
- Eichelberg, Christian, Vervenne, Walter L., De Santis, Maria, Fischer von Weikersthal, Ludwig, Goebell, Peter J., Lerchenmüller, Christian, Zimmermann, Uwe, Bos, Monique M.E.M., Freier, Werner, Schirrmacher-Memmel, Silke, Staehler, Michael, Pahernik, Sascha, Los, Maartje, Schenck, Marcus, Flörcken, Anne, van Arkel, Cornelis, Hauswald, Kirsten, Indorf, Martin, Gottstein, Dana, Michel, Maurice S., 2015. SWITCH : A randomised, sequential, open-label study to evaluate the efficacy and safety of Sorafenib-sunitinib versus Sunitinib-sorafenib in the treatment of metastatic renal cell cancer. European Urology, 68 (5), pp. 837-848
- De Santis, Maria, Bachner, Mark, Cerveny, M., Kametriser, G., Steininger, T., Konigsberg, R., Schratter-Sehn, A., Sedlmayer, F., Dittrich, C., 2015. Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery : a phase I trial. Annals of Oncology, 25 (9), pp. 1789-1794
- Cathomas, Richard, De Santis, Maria, Galsky, Matthew D., 2015. First-line treatment of metastatic disease : Cisplatin-ineligible patients. Hematology/Oncology Clinics of North America, 29 (2), pp. 329-340
- Sternberg, Cora N., Skoneczna, Iwona, Kerst, J. Martijn, Albers, Peter, Fosså, Sophie D., Agerbaek, Mads, Dumez, Herlinde, De Santis, Maria, Théodore, Christine, Leahy, Michael G., Chester, John D., Verbaeys, Antony, Daugaard, Gedske, Wood, Lori, Witjes, J. Alfred, de Wit, Ronald, Geoffrois, Lionel, Sengelov, Lisa, Thalmann, George, Charpentier, Danielle et al (Select to open full list), 2015. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3?pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994) : an intergroup, open-label, randomised phase 3 trial. The Lancet Oncology, 16 (1), pp. 76-86
- De Santis, Maria, Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W.-C., Albiges, L., Lin, C.-C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N., Culine, S., 2015. Vinflunine?gemcitabine versus vinflunine?carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma : results of an international randomized phase II trial (JASINT1). Annals of Oncology, 27 (3), pp. 449-454
- Fakhrejahani, Farhad, Tomita, Yusuke, Maj-Hes, Agnes, Trepel, Jane B., De Santis, Maria, Apolo, Andrea B., 2015. Immunotherapies for bladder cancer : a new hope. Current Opinion in Urology, 25 (6), pp. 504-509
- Mulders, Peter F., De Santis, Maria, Powles, Thomas, Fizazi, Karim, 2015. Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy. Cancer Immunology, Immunotherapy, 64 (6), pp. 655-663
- Bruins, Harman M., Veskimae, Erik, Hernandez, Virginia, Imamura, Mari, Neuberger, Molly M., Dahm, Philip, Stewart, Fiona, Lam, Thomas B., N'Dow, James, van der Heijden, Antoine G., Compérat, Eva, Cowan, Nigel C., De Santis, Maria, Gakis, Georgios, Lebret, Thierry, Ribal, Maria J., Sherif, Amir, Witjes, J. Alfred, 2014. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer : s systematic review. European Urology, 66 (6), pp. 1065-1077
- Mottet, Nicolas, Clarke, Noel W., De Santis, Maria, Zattoni, Filiberto, Morote, Juan, Joniau, Steven, 2014. Implementing newer agents for the management of castrate-resistant prostate cancer : what is known and what is needed?. BJU International, 115 (3), pp. 364-372
- Valdagni, Riccardo, Van Poppel, Hendrik, Aitchison, Michael, Albers, Peter, Berthold, Dominik, Bossi, Alberto, Brausi, Maurizio, Denis, Louis, Drudge-Coates, Lawrence, De Santis, Maria, Feick, Günther, Harrison, Chris, Haustermans, Karin, Hollywood, Donal, Hoyer, Morton, Hummel, Henk, Mason, Malcolm, Mirone, Vincenzo, Müller, Stefan C., Parker, Chris et al (Select to open full list), 2014. Prostate Cancer Unit Initiative in Europe : a position paper by the European School of Oncology. Critical Reviews in Oncology/Hematology, 95 (2), pp. 133-143
- Fitzpatrick, John M., Bellmunt, Joaquim, Fizazi, Karim, Heidenreich, Axel, Sternberg, Cora N., Tombal, Bertrand, Alcaraz, Antonio, Bahl, Amit, Bracarda, Sergio, Di Lorenzo, Giuseppe, Efstathiou, Eleni, Finn, Stephen P., Fosså, Sophie, Gillessen, Silke, Kellokumpu-Lehtinen, Pirkko-Liisa, Lecouvet, Frédéric E., Oudard, Stephane, de Reijke, Theo M., Robson, Craig N., De Santis, Maria et al (Select to open full list), 2014. Optimal management of metastatic castration-resistant prostate cancer : Highlights from a European Expert Consensus Panel. European Journal of Cancer, 50 (9), pp. 1617-1627
- Bellmunt, Joaquim, Orsola, A., Leow, J. J., Wiegel, Thomas, De Santis, Maria, Horwich, Alan, 2014. Bladder cancer : ESMO Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 25 (Supplement 3), pp. iii40-iii48
- Witjes, J. Alfred, Compérat, Eva, Cowan, Nigel C., De Santis, Maria, Gakis, Georgios, Lebret, Thierry, Ribal, Maria J., Van der Heijden, Antoine G., Sherif, Amir, 2014. EAU Guidelines on muscle-invasive and metastatic bladder cancer : summary of the 2013 guidelines. European Urology, 65 (4), pp. 778-792
- Oldenburg, J., Aparicio, J., Beyer, J., Cohn-Cedermark, G., Cullen, M., Gilligan, T., De Giorgi, U., De Santis, Maria, de Wit, R., Fossa, S. D., Germa-Lluch, J. R., Gillessen, S., Haugnes, H. S., Honecker, F., Horwich, A., Lorch, A., Ondru , D., Rosti, G., Stephenson, A. J., Tandstad, T., 2014. Personalizing, not patronizing : the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Annals of Oncology, 26 (5), pp. 833-838
- Jones, Robert, De Santis, Maria, 2013. Access to targeted therapies in renal cell cancer. Seminars in Oncology, 40 (4), pp. 521-528
- Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, Noel W., Classen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, Maria, De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K. et al (Select to open full list), 2013. Maintaining success, reducing treatment burden, focusing on survivorship : highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Annals of Oncology, 24 (4), pp. 878-888
- Ohlmann, C. -H., De Santis, Maria, 2013. Neoadjuvante, induktive oder adjuvante Chemotherapie des Blasenkarzinoms. Der Urologe. Section A: Zeitschrift fuer klinische und praktische Urologie, 52 (11), pp. 1534-1540
- Gakis, Georgios, Witjes, J. Alfred, Compérat, Eva, Cowan, Nigel C., De Santis, Maria, Lebret, Thierry, Ribal, Maria J., Sherif, Amir M., 2013. EAU Guidelines on primary urethral carcinoma. European Urology, 64 (5), pp. 823-830
- Porta, C., Tortora, G., Linassier, C., Papazisis, K., Awada, A., Berthold, D., Maroto, J. P., Powles, T., De Santis, Maria, 2012. Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents : an expert agreement. Medical Oncology, 29 (3), pp. 1896-1907
- Stenzl, A., Cowan, N. C., De Santis, Maria, Kuczyk, M. A., Merseburger, A. S., Ribal, M. J., Sherif, A., Witjes, J. A., 2012. Tratamiento del cáncer de vejiga con invasión muscular y metastásico : actualización de la Guía Clínica de la EAU. Actas Urologicas Espanolas, 36 (8), pp. 449-460
- Bachner, Mark, Loriot, Y., Gross-Goupil, M., Zucali, P. A., Horwich, A., Germa-Lluch, J.- R., Kollmannsberger, C., Stoiber, F., Flechon, A., Oechsle, K., Gillessen, S., Oldenburg, J., Cohn-Cedermark, G., Daugaard, G., Morelli, F., Sella, A., Harland, S., Kerst, M., Gampe, J., Dittrich, C. et al (Select to open full list), 2012. 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions : a retrospective validation of the SEMPET trial. Annals of Oncology, 23 (1), pp. 59-64
- Rauchenwald, Michael, Krainer, Michael, Bauernhofer, Thomas, De Santis, Maria, Höltl, Wolfgang, Kramer, Gero, Krause, Steffen, Loidl, Wolfgang, Oismüller, Renée, Reissigl, Andreas, Schmeller, Nikolaus, Stackl, Walter, Stoiber, Franz, Füreder, Thorsten, 2012. Therapie des kastrationsrefraktären Prostatakarzinoms. Wiener klinische Wochenschrift, 124 (15-16), pp. 538-551
- Bellmunt, Joaquim, von der Maase, Hans, Mead, Graham M., Skoneczna, Iwona, De Santis, Maria, Daugaard, Gedske, Boehle, A., Chevreau, C., Paz-Ares, Luis, Laufman, L. R., Winquist, E., Raghavan, D., Marreaud, Sandrine, Collette, S., Sylvester, Richard, de Wit, Ronald, 2012. Randomized phase III study comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy : EORTC Intergroup Study 30987. Journal of Clinical Oncology, 30 (10), pp. 1107-1113
- De Santis, Maria, Bellmunt, Joaquim, Mead, G., Kerst, J. M., Leahy, Michael G., Maroto, P., Gil, T., Marreaud, Sandrine, Daugaard, Gedske, Skoneczna, Iwona, Collette, S., Lorent, J., de Wit, Ronald, Sylvester, Richard, 2012. Randomized Phase II/III Trial assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in patients with advanced Urothelial cancer who are unfit for Cisplatin-based chemotherapy : EORTC Study 30986. Journal of Clinical Oncology, 30 (2), pp. 191-199
- De Santis, Maria, Bellmunt, Joaquim, Mead, Graham M., Kerst, J. M., Leahy, Michael G., Maroto, P., Gil, T., Marreaud, Sandrine, Daugaard, Gedske, Skoneczna, Iwona, Collette, S., Lorent, J., de Wit, Ronald, Sylvester, Richard, 2012. Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in patients with advanced Urothelial cancer who are unfit for Cisplatin-based chemotherapy : EORTC Study 30986. Journal of Clinical Oncology, 30 (2), pp. 191-199
- De Santis, Maria, Albers, P., Bokemeyer, C., 2012. Erstlinienchemotherapie beim Harnblasenkarzinom. Der Onkologe, 18 (11), pp. 1012-1017
- De Santis, Maria, Bachner, Mark, 2012. Rolle der Chemotherapie beim kastrationsresistenten Prostatakarzinom. Der Urologe. Section A: Zeitschrift fuer klinische und praktische Urologie, 51 (1), pp. 39-43
- Albers, Peter, Algaba, Ferran, Cohn-Cedermark, Gabriella, De Santis, Maria, Kliesch, Sabine, Moul, Judd W., 2011. Diagnosis, staging, and risk factors : SIU/ICUD consensus meeting on germ cell Tumors (GCT), Shanghai 2009. Urology, 78 (4), pp. S427-S434
- Stenzl, Arnulf, Cowan, Nigel C., De Santis, Maria, Kuczyk, Markus A., Merseburger, Axel S., Ribal, Maria José, Sherif, Amir, Witjes, J. Alfred, 2011. Treatment of muscle-invasive and metastatic bladder cancer : update of the EAU guidelines. European Urology, 59 (6), pp. 1009-1018
- Cathomas, Richard, Hartmann, Michael, Krege, Susanne, Souchon, Rainer, Lorch, Anja, Mayer, Frank, De Santis, Maria, Gillessen, Silke, 2011. Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients. Onkologie, 34 (1-2), pp. 59-64
- Königsberg, Robert, Obermayr, Eva, Bises, Giovanna, Pfeiler, Georg, Gneist, Margit, Wrba, Fritz, De Santis, Maria, Zeillinger, Robert, Hudec, Marcus, Dittrich, Christian, 2011. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncologica, 50 (5), pp. 700-710
- Hartmann, M., Krege, S., Souchon, R., De Santis, Maria, Gillessen, S., Cathomas, R., 2011. Nachsorge von Patienten mit Hodentumoren. Der Urologe. Section A: Zeitschrift fuer klinische und praktische Urologie, 50 (7), pp. 830-835
- Souchon, Rainer, Hartmann, Michael, Krege, Susanne, Lorch, Anja, Mayer, Frank, De Santis, Maria, Gillessen, Silke, Beyer, Jörg, Cathomas, Richard, 2011. Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients. Strahlentherapie und Onkologie, 187 (3), pp. 158-166
- Stenzl, A., Cowan, N. C., De Santis, Maria, Jakse, G., Kuczyk, M. A., Merseburger, A. S., Ribal, M. J., Sherif, A., Witjes, J. A., 2010. Actualización de las Guías Clínicas de la Asociación Europea de Urología sobre el carcinoma vesical músculo-invasivo y metastásico. Actas Urologicas Espanolas, 34 (1), pp. 51-62
- Cathomas, Richard, Helbling, Daniel, Stenner, Frank, Rothermundt, Christian, Rentsch, Cyrill, Shahin, Osama, Seifert, Hans-Helge, Zaugg, Kathrin, Lorch, Anja, Mayer, Frank, Beyer, Jörg, De Santis, Maria, Gillessen, Silke, 2010. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients : a joint effort. Swiss medical weekly, 140 (25-26), pp. 356-69
- Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, Maria, Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C., Schmoll, H. J., 2010. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). Annals of Oncology, 22 (5), pp. 1054-1061
- Bachner, Mark, De Santis, Maria, 2009. Second-line therapy in bladder cancer. Current Opinion in Urology, 19 (5), pp. 533-539
- Stenzl, Arnulf, Cowan, Nigel C., De Santis, Maria, Jakse, Gerhard, Kuczyk, Marcus A., Merseburger, Axel S., Ribal, Maria José, Sherif, Amir, Witjes, J. Alfred, 2009. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. European Urology, 55 (4), pp. 815-825
- De Santis, Maria, Bellmunt, Joaquim, Mead, Graham M., Kerst, J. Martijn, Leahy, Michael G., Maroto, P., Skoneczna, Iwona, Marreaud, Sandrine, de Wit, Ronald, Sylvester, Richard, 2009. Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in patients with advanced Urothelial cancer "unfit" for Cisplatin-Based chemotherapy : Phase II--Results of EORTC Study 30986. Journal of Clinical Oncology, 27 (33), pp. 5634-5639
- Fizazi, K., Oldenburg, J., Dunant, A., Chen, I., Salvioni, R., Hartmann, J. T., De Santis, Maria, Daugaard, G., Flechon, A., de Giorgi, U., Tjulandin, S., Schmoll, H. J., Bouzy, J., Fossa, S. D., Fromont, G., 2008. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT) : results of the sCR2 international study. Annals of Oncology, 19 (2), pp. 259-264
- Rauchenwald, Michael, De Santis, Maria, Fink, Eleonore, Höltl, Wolfgang, Kramer, Gero, Marei, Isabella-Carolina, Neumann, Hans-Jörg, Reissigl, Andreas, Schmeller, Nikolaus, Stackl, Walter, Hobisch, Alfred, Krainer, Michael, 2008. Chemotherapie beim Prostatakarzinom. Wiener klinische Wochenschrift, 120 (13-14), pp. 440-449
- Krege, Susanne, Beyer, Jörg, Souchon, Rainer, Albers, Peter, Albrecht, Walter, Algaba, Ferran, Bamberg, Michael, Bodrogi, István, Bokemeyer, Carsten, Cavallin-Ståhl, Eva, Classen, Johannes, Clemm, Christoph, Cohn-Cedermark, Gabriella, Culine, Stéphane, Daugaard, Gedske, De Mulder, Pieter H.M., De Santis, Maria, de Wit, Maike, de Wit, Ronald, Derigs, Hans Günter et al (Select to open full list), 2008. European consensus conference on diagnosis and treatment of germ cell cancer : a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG) : Part II. European Urology, 53 (3), pp. 497-513
- Königsberg, Robert, Rögelsperger, Olga, Jäger, Walter, Thalhammer, Theresia, Klimpfinger, Martin, De Santis, Maria, Hudec, Marcus, Dittrich, Christian, 2008. Cell cycle dysregulation influences survival in high risk breast cancer patients. Cancer Investigation, 26 (7), pp. 734-740
- Sellner, F., Sobhian, B., De Santis, Maria, Pont, J., Staettner, St., Sellner, St., Karner, J., Klimpfinger, M., 2008. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas : a single institution experience with 17 cases. European Journal of Surgical Oncology (EJSO), 34 (2), pp. 191-195
- Krege, Susanne, Beyer, Jörg, Souchon, Rainer, Albers, Peter, Albrecht, Walter, Algaba, Ferran, Bamberg, Michael, Bodrogi, István, Bokemeyer, Carsten, Cavallin-Ståhl, Eva, Classen, Johannes, Clemm, Christoph, Cohn-Cedermark, Gabriella, Culine, Stéphane, Daugaard, Gedske, De Mulder, Pieter H.M., De Santis, Maria, de Wit, Maike, de Wit, Ronald, Derigs, Hans Günter et al (Select to open full list), 2008. European consensus conference on diagnosis and treatment of germ cell cancer : a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG) : Part I. European Urology, 53 (3), pp. 478-496
- De Santis, Maria, Galsky, Matthew D., 2015. Treatment of poor risk patients. Bladder cancer : diagnosis and clinical management, Oxford, Wiley-Blackwell Publishing Ltd
- Cathomas , R., De Santis, Maria, Galsky, M. D., 2015. First line treatment of metastatic disease : Cisplatin-Ineligible patients. Bellmunt, Joaquim (ed.), Bladder Cancer, an issue of Hematology/Oncology Clinics of North America, Amsterdam ; Oxford, Elsevier
- De Santis, Maria, Steininger, Tanja, 2014. Monozentrische Studie. In Lenk , Christian; Duttge, Gunnar; Fangerau, Heiner (eds.), Handbuch Ethik und Recht der Forschung am Menschen, Springer Netherlands, pp. 613-616
- De Santis, Maria, Steininger , Tanja, 2014. Lebensqualität ? quality of life (QoL). In Lenk, Christian; Duttge, Gunnar; Fangerau, Heiner (eds.), Handbuch Ethik und Recht der Forschung am Menschen, Berlin Heidelberg, Springer, pp. 191-196
- De Santis, Maria, 2011. Chemotherapy for metastatic bladder cancer. In Lokeshwar, Vinata B.; Merseburger, Axel S.; Hautmann, Stefan H. (eds.), Bladder Tumors : Molecular Aspects and Clinical Management, Humana Press, pp. 409-431
- De Santis, Maria, Bachner, Mark, Lawrentschuk, N., Jack, G. S., Bolton, D. M., 2010. Radiographic diagnosis and staging. In Laguna, M. Pilar; Albers, Peter; Richie, Jerome P; Bokemeyer, Carsten (eds.), Cancer of the Testis, London, Springer, pp. 75-94
- De Santis, Maria, Maj Hes , A., Bachner, Mark, 2009. Positron emission tomography (PET) in germ cell tumors (GCT). In Rosette, J. J. M. C. H.; Manyak, M. J.; Harisinghani, M. G.; Wijkstra, H. (eds.), Imaging in Oncological Urology, London, Springer-Verlag, pp. 305-313
- De Santis, Maria, Strau, G., Bachner, Mark, 2009. Cross-sectional imaging techniques : the use of computed tomography (CT) and magnetic resonance imaging (MRI) in the management of germ cell tumors. In Rosette, J. J. M. C. H.; Manyak, M. J.; Harisinghani, M. G.; Wijkstra, H. (eds.), Imaging in Oncological Urology, London, Springer-Verlag, pp. 287-303
- De Santis, Maria, Bachner, Mark, 2012. DFP-Literaturstudium - Therapie von Malignomen. Österreichische Ärzte Zeitung ÖÄZ, Verlagshaus der Ärzte Gesellschaft
- Stenzl, Arnulf, Cowan, Nigel C., De Santis, Maria, Kuczyk, Markus A., Merseburger, Axel S., Ribal, Maria José, Sherif, Amir, Witjes, J. Alfred, Lebret, Thierry, 2012. Reply to Santhanam Sundar's Letter to the Editor re : Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer : Update of the EAU Guidelines. Eur Urol 2011;59:1009?18. European Urology, Elsevier BV, pp. e45-e46
- Bachner, Mark, De Santis, Maria, 2008. Vinfl unine in the treatment of bladder cancer. Therapeutics and Clinical Risk Managemen, Dove Medical Press, pp. 1243-1253